tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jim Birchenough, 68 are a HOLD (30.36%), 154 are a BUY (68.75%), 2 are a SELL (0.89%).
Analyst Jim Birchenough, currently employed at WELLS FARGO, carries an average stock price target met ratio of 69.26% that have a potential upside of 43.24% achieved within 433 days. Previously, Jim Birchenough worked at BMO.
Jim Birchenough’s has documented 432 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SGMO, Sangamo Therapeutics at 02-Jan-2025.
Analyst best performing recommendations are on INFI (INFINITY PHARMACEUTICALS).
The best stock recommendation documented was for BIIB (BIOGEN) at 7/23/2015. The price target of $360 was fulfilled within 1 day with a profit of $25.05 (6.51%) receiving and performance score of 65.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2017
$30
6 years 1 months 23 days ago
(01-Sep-2020)
2/8 (25%)
$14.76 (96.85%)
30
Hold Since 25-Sep-2018
$20
$1.83 (10.07%)
$31
6 years 5 months 18 days ago
(06-May-2020)
1/2 (50%)
$4.76 (31.23%)
9
Hold Since 07-Oct-2019
$24
7 years 17 days ago
(07-Oct-2019)
3/4 (75%)
$5.96 (33.04%)
44
Buy Since 07-Oct-2019
$45
$26.83 (147.66%)
$45
7 years 17 days ago
(07-Oct-2019)
0/2 (0%)
$25.13 (126.47%)
Hold Since 07-Aug-2018
8 years 29 days ago
(25-Sep-2018)
3/3 (100%)
$-5.99 (-15.36%)
24
What Year was the first public recommendation made by Jim Birchenough?
